GE9-25175-19499
4 vaccinations
3 coded responses
13 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 360 / AL
- Registered
- 2021-02-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Registered in v-safe
- 2021-02-20
-
2021-02-27
Dose 2 — Pfizer-BioNTech
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-03-06
- 2021-05-29
- 2021-08-28
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Injection site erythema, Injection site mass, Injection site pain, Injection site pruritus, Injection site swelling — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessFree text: Injection site soreness and swelling lingers a long time for me with each shot. Large lump under injection site. Itches. Redness has spread larger daily but started to improve in past 24 hrs. Otherwise I feel fine.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Health check-in — day 7, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-10-28
-
2022-03-31
Survey response — 6 months, dose 3MedDRA: Pulmonary embolism — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Double pulmonary embolism in January 2022.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-04-05
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-13
Dose 4 — Pfizer-BioNTech
-
2022-09-17
Survey response — days 1–6 daily, dose 4MedDRA: Injection site erythema, Injection site irritation, Injection site pain, Injection site swelling, Pruritus, Vaccine positive rechallenge — Feeling: Good · Site: Redness, Swelling, ItchingFree text: I have A LOT of irritation around the injection site with each covid dose, but dont with other vaccines. The itching is better today, but the first few days it was extreme. There is a large goose egg at the injection site and it is still red and soreMedDRA releases: 2024-11 · check-in free text available
-
2022-09-18
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2022-09-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | |
| 2 | 2021-02-27 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Injection site soreness and swelling lingers a long time for me with each shot. Large lump under injection site. Itches. Redness has spread larger daily but started to improve in past 24 hrs. Otherwise I feel fine.
Release 11 — 6 months, dose 3
Symptoms: Double pulmonary embolism in January 2022.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): I have A LOT of irritation around the injection site with each covid dose, but dont with other vaccines. The itching is better today, but the first few days it was extreme. There is a large goose egg at the injection site and it is still red and sore cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pulmonary embolism | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site irritation | · | · | ✓ |
| SRO | Injection site mass | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Vaccine positive rechallenge | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release